TipRanks
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh (BR:A1LN34)
:A1LN34
Brazil Market
A1LN34
Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh
RESEARCH TOOLSreports

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh (A1LN34) Stock News & Sentiment

― Followers
Alnylam: Brezosiran Pivotal Path and Pipeline Strength Underpin Buy Rating; $320 Price Target Reiterated
Premium
Ratings
Alnylam: Brezosiran Pivotal Path and Pipeline Strength Underpin Buy Rating; $320 Price Target Reiterated
5d ago
ALNY
Analyst Maintains Hold Rating and Keeps $300 Price Target Unchanged Amid Promising Early Huntington’s Data and Long Development Timeline
Premium
Ratings
Analyst Maintains Hold Rating and Keeps $300 Price Target Unchanged Amid Promising Early Huntington’s Data and Long Development Timeline
5d ago
ALNY
Alnylam: Early Brezosiran Data and Emerging CNS Franchise Support $336 Price Target and Maintained Buy Rating
Premium
Ratings
Alnylam: Early Brezosiran Data and Emerging CNS Franchise Support $336 Price Target and Maintained Buy Rating
6d ago
ALNY
Analyst Maintains Buy Rating on Alnylam, Reiterates $357 Price Target on Long-Term Zilebesiran Opportunity
Premium
Ratings
Analyst Maintains Buy Rating on Alnylam, Reiterates $357 Price Target on Long-Term Zilebesiran Opportunity
1M ago
ALNY
Hold Rating Reaffirmed as TTR Outlook Moderates; $300 Price Target Maintained
Premium
Ratings
Hold Rating Reaffirmed as TTR Outlook Moderates; $300 Price Target Maintained
2M ago
ALNY
Alnylam’s Emerging TTR Leadership Reinforces Buy Rating with Unchanged $455 Price Target
Premium
Ratings
Alnylam’s Emerging TTR Leadership Reinforces Buy Rating with Unchanged $455 Price Target
2M ago
ALNY
Whitney Ijem Reiterates Buy on Alnylam, Keeps Price Target Unchanged at $429 Following CARDIO‑TTRansform Data
Premium
Ratings
Whitney Ijem Reiterates Buy on Alnylam, Keeps Price Target Unchanged at $429 Following CARDIO‑TTRansform Data
2M ago
ALNY
More BR:A1LN34 News >

A1LN34 News on the Web

Wells Fargo Remains a Hold on Alnylam Pharma (ALNY)
TipRanks News
Neutral
Alnylam price target lowered to $220 from $253 at Wells Fargo
TipRanks News
Bearish
Alnylam downgraded to Outperform from Strong Buy at Raymond James
TipRanks News
Bearish
Alnylam price target lowered to $375 from $425 at Chardan
TipRanks News
Bearish
Alnylam: Early Brezosiran Data and Emerging CNS Franchise Support $336 Price Target and Maintained Buy Rating
TipRanks News
Bullish
Analyst Maintains Buy Rating on Alnylam, Reiterates $357 Price Target on Long-Term Zilebesiran Opportunity
TipRanks News
Bullish
Hold Rating Reaffirmed as TTR Outlook Moderates; $300 Price Target Maintained
TipRanks News
Neutral
Alnylam Maintained at Buy as Analyst Reaffirms $346 Price Target on TTR Franchise Strength and Amvuttra Growth Visibility
TipRanks News
Bullish

News Score - Last 7 Days

Negative
BR:A1LN34
Sector Average
Media Buzz
This Week31 articles
Weekly Average2.75 articles
News Sentiment
This Week39%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is BR:A1LN34’s Media Buzz Sentiment?
31 articles about BR:A1LN34 were published this week. In an average week, 2.75 articles are published.
    What is BR:A1LN34’s weekly average amount of articles?
    In an average week, 2.75 articles about BR:A1LN34 are published.
      What is BR:A1LN34’s News Sentiment?
      39% of articles about BR:A1LN34 were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week